Can you lower cholesterol without medication?
On this page
Yes, by a measurable amount. Single food changes took LDL down about 7 to 13 mg/dL in trials, and the full portfolio diet lowered it 28.6% in a month. If the gap between your LDL and your goal is bigger than that, medicine is the conversation to have.
What we’d do
Try food first if your gap is small, say 30 points or less at borderline or intermediate risk, and retest in 6 to 12 weeks. If your LDL is 190 or more, you’ve had a heart attack or stroke, or you have diabetes and you’re 40 or older, food goes alongside the medicine your doctor offers. If you already take a statin, never stop it on your own.
Why people want to avoid medicine
Nobody wants a pill for life, and supplements sold as “natural” alternatives promise the same thing without one. Food really can lower LDL, but supplements haven’t. In the SPORT trial, six popular supplements (fish oil, cinnamon, garlic, turmeric, plant sterols and red yeast rice) did no better than a placebo in 28 days, while a 5 mg statin lowered LDL 35% more than placebo.
What food can do
| Change | LDL, in trials |
|---|---|
| 10 g of psyllium husk a day | about 13 lower |
| 5% of calories moved from saturated fat to vegetable oils | about 11 lower |
| About 3.5 g of oat beta-glucan a day | about 7 lower |
| The portfolio diet for a month | 28.6% lower |
In the portfolio trial, 46 adults with high cholesterol ate soy protein, almonds, viscous fiber and a margarine with added plant sterols for a month. Their LDL fell 28.6%. A group on a starter statin fell 30.9%, and the difference was too small to call. Single changes don’t add up neatly, and nobody has measured how much they overlap.
Do the gap math
Take an LDL of 160 and a goal of under 100. The gap is 60 points.
| Option | From 160 |
|---|---|
| Psyllium alone | about 13 |
| The fat swap alone | about 11 |
| The full portfolio diet | about 46 |
| A moderate-intensity statin (30 to 49%) | about 48 to 78 |
| A high-intensity statin (50% or more) | 80 or more |
Food is like taking the stairs and medicine is the elevator. Both get you down, and how many floors you need to go decides which one makes sense.
The argument against food alone
The food trials measured LDL for weeks. They didn’t count heart attacks. The case that lower LDL prevents heart attacks comes from drug trials and from genes. In 26 statin trials with about 170,000 people, each 39 mg/dL lower LDL cut heart attacks, strokes and artery procedures together by about a fifth, and deaths from any cause by 10%. No food trial has shown that LDL lowered by food protects in the same way, though it’s the same LDL.
The 2026 guideline says the direct effect of healthy eating on LDL “tends to be more modest”, and that people vary in how much they respond. Food works best when the gap is small and you start early. See when medicine is the conversation to have for where the guideline draws the lines.
8 sources
- Jovanovski E and others, Effect of psyllium fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B, American Journal of Clinical Nutrition, 2018pubmed.ncbi.nlm.nih.gov
- Mensink RP, Effects of saturated fatty acids on serum lipids and lipoproteins, World Health Organization, 2016, as tabulated by Food Standards Australia New Zealandfoodstandards.gov.au
- Ho HV and others, The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction, British Journal of Nutrition, 2016pubmed.ncbi.nlm.nih.gov
- Jenkins DJ and others, Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein, JAMA, 2003pubmed.ncbi.nlm.nih.gov
- Laffin LJ and others, Comparative effects of low-dose rosuvastatin, placebo, and dietary supplements on lipids and inflammatory biomarkers, Journal of the American College of Cardiology, 2023pubmed.ncbi.nlm.nih.gov
- Cholesterol Treatment Trialists' Collaboration, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 2010pubmed.ncbi.nlm.nih.gov
- Blumenthal RS, Morris PB, Gaudino M and others, 2026 ACC/AHA guideline on the management of dyslipidemia, JACC, 2026doi.org
- The same guideline, full text, Circulation, 2026api.iscpcardio.org
